1. Neville BW, Damm DD, Allen CM, Chi AC. Oral and maxillofacial pathology. 4th ed. St. Louis: Saunders Elsevier; 2016. p. 708-25

2. ncbi.nlm.nih.gov. National library of medicine [Internet]. 1998. Available from: https://www.ncbi.nlm.nih.gov/mesh/68009273.

3. Kong َYL, Lim YL, Chandran NS. Retrospective Study on Autoimmune Blistering Disease in Pediatric Patients. Pediatr Dermatol. 2015 Nov-Dec;32(6):845-52. doi: 10.1111/pde.12684. Epub 2015 Sep 22. PMID: 26391853. [DOI:10.1111/pde.12684] [PMID]

4. Mahajan R, Handa S, Kumar S, Chatterji D, Saikia UN, De D. Pediatric autoimmune blistering disorders - a five-year demographic profile and therapy experience. Int J Dermatol. 2022 Dec;61(12):1511-1518. doi: 10.1111/ijd.16314. Epub 2022 Jul 27. PMID: 35894223. [DOI:10.1111/ijd.16314] [PMID]

5. Abdolsamadi HR, Abdollahzadeh S, Bakianian Vaziri P, Beheshti A, Shafigh E, Vahedi M. Epidemiology of pemphigus in Tehran, Iran: a 20-year retrospective study. J Dent Res Dent Clin Dent Prospects. 2007 Fall;1(3):108-13. Doi: 10.5681/joddd.2007.019.

6. Nanda A, Lazarevic V, Rajy JM, Almasry IM, AlSabah H, AlLafi A. Spectrum of autoimmune bullous diseases among children in Kuwait. Pediatr Dermatol. 2021 Jan;38(1):50-57. doi: 10.1111/pde.14368. Epub 2020 Oct 11. PMID: 33043506. [DOI:10.1111/pde.14368] [PMID]

7. Welfringer-Morin A, Bekel L, Bellon N, Gantzer A, Boccara O, Hadj-Rabia S, Leclerc-Mercier S, Frassati-Biaggi A, Fraitag S, Bodemer C. Long-term evolving profile of childhood autoimmune blistering diseases: Retrospective study on 38 children. J Eur Acad Dermatol Venereol. 2019 Jun;33(6):1158-1163. doi: 10.1111/jdv.15456. Epub 2019 Mar 14. PMID: 30702174. [DOI:10.1111/jdv.15456] [PMID]

8. Asilian A, Yoosefi A, Faghini G. Pemphigus vulgaris in Iran: epidemiology and clinical profile. Skinmed. 2006;5(2):69-71. Doi: 10.1111/j.1540-9740.2006.03756.x. [DOI:10.1111/j.1540-9740.2006.03756.x] [PMID]

9. Gholpour M, Rahmatpour Rokni G, Rahmani M, Gholpour B, Heidari Gorji A. Epidemiologic evaluation of patients with blistering lesions in Sari: a retrospective study. JPAD. 2018;27(3):214-9.

10. Marazza G, Pham HC, Schärer L, Pedrazzetti PP, Hunziker T, Trüeb RM, et al. Incidence of bullous pemphigoid in Switzerland: a 2-year prospective study. Br J Dermatol. 2009;161(4): 861-8. Doi: 10.1111/j.1365-2133.2009.09300.x. [DOI:10.1111/j.1365-2133.2009.09300.x] [PMID]

11. Sobhan M, Farshchian M, Tamimi M. Spectrum of autoimmune vesiculobullous diseases in Iran: a 13-year retrospective study. Clin Cosmet Investig Dermatol. 2016;9:15-20. Doi: 10.2147/CCID.S97214. [DOI:10.2147/CCID.S97214] [PMID] []

12. Esmaili N, Chams-Davatchi C, Valikhani M, Daneshpazhooh M, Toosi S, Karimi A, et al. Assessment of the therapeutic benefit of oral prednisolone and common adjuvant therapy in stage II of randomized controlled trial study for management of pemphigus vulgaris. Arch Iran Med. 2014;17(9):626-8.

13. Goncalo RIC, Severo MLB, Medeiros AMC, Oliveira PT, Silveira ÉJDD. Vesiculobullous autoimmune diseases with oral mucosa manifestations: retrospective and follow-up study. Rev Gaucha Odontol. 2018; 66(1):42-9. Doi: 10.1590/1981-863720180001000063368. [DOI:10.1590/1981-863720180001000063368]

14. Jowkar F, Sadati MS, Tavana S, Agah MA. Epidemiology of autoimmune bullous diseases and therapeutic modalities during a 10-year period in Iran. Acta Dermatovenerol Croat. 2014;22(4):246-9.

15. Hicham T, Chahnoun FZ, Hanafi T, Hjira N, Mohammed B. Pemphigus Vulgaris: A Clinical Study of 31 Cases (2004-2014) in Morocco. Dermatol Res Pract. 2020;2020:8535109. Doi: 10.1155/2020/8535109. [DOI:10.1155/2020/8535109] [PMID] []

16. Siddig O, Mustafa MB, Kordofani Y, Gibson J, Suleiman AM. The epidemiology of autoimmune bullous diseases in Sudan between 2000 and 2016. PLoS One. 2021;16(7):e0254634. Doi: 10.1371/journal.pone.0254634. [DOI:10.1371/journal.pone.0254634] [PMID] []

17. Daneshpazhooh M, Chams-Davatchi C, Payandemehr P, Nassiri S, Valikhani M, Safai-Naraghi Z. Spectrum of autoimmune bullous diseases in Iran: a 10-year review. Int J Dermatol. 2012;51(1):35-41. Doi: 10.1111/j.1365-4632.2011.04946.x. [DOI:10.1111/j.1365-4632.2011.04946.x] [PMID]

18. Hübner F, König IR, Holtsche MM, Zillikens D, Linder R, Schmidt E. Prevalence and age distribution of pemphigus and pemphigoid diseases among paediatric patients in Germany. J Eur Acad Dermatol Venereol. 2020 Nov;34(11):2600-2605. doi: 10.1111/jdv.16467. Epub 2020 Jun 29. PMID: 32289873. [DOI:10.1111/jdv.16467] [PMID]

19. Zaraa I, Kerkeni N, Ishak F, Zribi H, El Euch D, Mokni M, et al. Spectrum of autoimmune blistering dermatoses in Tunisia: an 11-year study and a review of the literature. Int J Dermatol. 2011;50(8):939-44. Doi: 10.1111/j.1365-4632.2010.04801.x [DOI:10.1111/j.1365-4632.2010.04801.x] [PMID]

20. Joly P, Baricault S, Sparsa A, Bernard P, Bedane C, Duvert-Lehembre S, et al. Incidence and mortality of bullous pemphigoid in France. J Invest Dermatol. 2012;132(8):1998-2004. Doi: 10.1038/jid.2012.35. [DOI:10.1038/jid.2012.35] [PMID]

21. Brick KE, Weaver CH, Lohse CM, Pittelkow MR, Lehman JS, Camilleri MJ, et al. Incidence of bullous pemphigoid and mortality of patients with bullous pemphigoid in Olmsted County, Minnesota, 1960 through 2009. J AmAcad Dermatol. 2014;71(1):92-9. Doi: 10.1016/j.jaad.2014.02.030. [DOI:10.1016/j.jaad.2014.02.030] [PMID] []